Safety and Efficacy Assessment of Using the zLOCK Facet Stabilization System

February 6, 2024 updated by: ZygoFix

The zLOCK Facet Stabilization System is a fixation device intended to provide posterior stability in the lumbar spine fusion procedure. The system can be placed either as an adjunct to an inter-vertebral anterior cage or as stand-alone with/ without additional decompression of the dural sac or nerve roots as appropriate for the specific patient and surgeon's discretion. The zLOCK implant is placed inside the facet to stabilize the motion and enhance the bony fusion of the joint. The zLOCK Facet Stabilization System is intended for single-level stabilization of a spinal motion segment in order to promote bony fusion of the joint. The zLOCK system is indicated for use from L1-L2 to L5-S1 joints.

The zLOCK implant is inserted into the facet joint space while adapting to the joint's changing geometry. Stabilization is achieved by a firm grip of each joint bone and resisting any relative motion. The zLOCK implant is placed percutaneously and requires only one incision per side, thereby reducing the invasiveness procedure duration and shortening the recovery period.

This pivotal study was designed in order to assess the safety and effectiveness of the zLOCK system.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Rostock, Germany, 18055
        • Recruiting
        • MedizinischenFakultät der Universität Rostock
        • Contact:
      • Palermo, Italy
        • Recruiting
        • AOU Policlinico "Paolo Giaccone"
        • Contact:
        • Principal Investigator:
          • Giovanni Grasso, Prof.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 73 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patient is scheduled for spine surgery with at least one of the following:

    • Degenerative Spondylolisthesis grade 1;
    • Mild to Moderate stenosis;
    • Degeneration of the facets.
  2. When used stand-alone disc height should be maximum 50% of the adjacent disc height.
  3. 18< Age <75
  4. Weight < 100Kg
  5. Signed informed consent form
  6. At least 3 months of unsuccessful conventional treatments

Exclusion Criteria:

  1. Fusion procedure performed or required in more than one motion segment.
  2. Acute or chronic spinal infections.
  3. Osteoporosis when used in adjunct to an anterior interbody cage (DEXA < -2.5).
  4. Absence of posterior spinal elements including the pedicle, pars interarticularis, facet joints, spinous process and the majority of the lamina which make it unstable or not possible to place.
  5. Any entity or conditions that totally preclude the possibility of fusion, i.e. cancer or kidney dialysis.
  6. Obesity (BMI ≥30)
  7. Unilateral application of device, except in combination with anterior interbody cages.
  8. Known sensitivity to Titanium.
  9. Alcoholism, or drug abuse
  10. Subject with a cardiac pacemaker or other implanted electro medical device
  11. Women who are either pregnant or nursing at the time of screening (to be verified by test in case of woman of child-bearing potential that do not practice medically acceptable methods of contraception)
  12. Concurrent participation in another clinical trial using any investigational drug or device.
  13. Mental disorders.
  14. Tumor
  15. Fracture or other instabilities of the posterior elements.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: zLock Facet Locking Implant System
Device: zLOCK Facet Stabilization System zLOCK Facet Stabilization System is a device intended to provide posterior stability in lumbar spine in order to reduce lumbar back pains
zLOCK Facet Stabilization System is a device intended to provide posterior stability in lumbar spine in order to reduce lumbar back pains

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Treatment-Emergent Adverse Events as assessed by paucity of device related reoperation
Time Frame: 3 months
The safety of the zLOCK Facet Implant System will be established based on the paucity of device-related reoperations.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pain level measured by Visual Analog Score for pain
Time Frame: 1 year

The efficacy assessment of the ZygoFix Facet stabilization System will be established by change in pain level

.

1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Hanna Levy, Dr., ZygoFix

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 7, 2021

Primary Completion (Estimated)

January 30, 2025

Study Completion (Estimated)

September 30, 2025

Study Registration Dates

First Submitted

February 13, 2022

First Submitted That Met QC Criteria

February 23, 2022

First Posted (Actual)

March 4, 2022

Study Record Updates

Last Update Posted (Estimated)

February 7, 2024

Last Update Submitted That Met QC Criteria

February 6, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • DMS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on zLOCK Facet Stabilization System

3
Subscribe